Peptide-derived KDM5C targeting cancer therapeutics patent grant
Summary
USPTO granted Patent US12589160B2 to NUVOBIO CORPORATION covering peptide-derived therapeutics targeting KDM5C for cancer treatment. The patent, filed on March 12, 2020, contains 6 claims and names inventors Kyle Kevin Biggar, Hemanta Adhikary, and Matthew Jacob Hoekstra. This grant establishes exclusive intellectual property rights for the assignee in the United States.
What changed
USPTO issued Patent US12589160B2 to NUVOBIO CORPORATION for peptide compositions that bind KDM5C for cancer treatment. The patent claims priority to Application No. 17438925, filed March 12, 2020, and includes 6 claims covering the peptide therapeutics and their use in treating cancer (CPC: A61P 35/00). The invention relates to therapeutic applications of KDM5C-targeting peptides.
Patent holders should review the granted claims to assess their competitive landscape and consider filing complementary patents in related jurisdictions. Competitors developing KDM5C-targeting cancer therapeutics should evaluate potential infringement risks and consider design-around strategies. The patent maintains coverage through its term based on the 2020 filing date.
Archived snapshot
Mar 31, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Peptide-derived therapeutics targeting KDM5C for the treatment of cancer
Grant US12589160B2 Kind: B2 Mar 31, 2026
Assignee
NUVOBIO CORPORATION
Inventors
Kyle Kevin Biggar, Hemanta Adhikary, Matthew Jacob Hoekstra
Abstract
The present invention relates to treatment of cancer. In particular, the present invention relates to peptides that bind KDM5C for the treatment of cancer.
CPC Classifications
A61K 47/645 A61K 38/00 A61P 35/00 C07K 7/06 C07K 7/08 C07K 2319/10 C12N 9/0071 C12Y 114/11
Filing Date
2020-03-12
Application No.
17438925
Claims
6
Related changes
Get daily alerts for USPTO Patent Grants - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.